AveXis Presents Promising Clinical Trial Results of Gene Therapy for Type 1 SMA – SMA News Today
SMA News Today |
AveXis Presents Promising Clinical Trial Results of Gene Therapy for Type 1 SMA
SMA News Today The pharmaceutical company AveXis recently presented the latest data about its clinical trial for AVXS-101, a gene therapy for infants with type 1 SMA. The one-time infusion is designed to correct the faulty gene responsible for spinal muscular atrophy … AveXis Inc (AVXS) VP Sells $135587.53 in Stock |
